Profound Medical Corp. | Income Statement
Fiscal year is January-December. All values CAD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
4,904.60
2,602.30
Cost of Goods Sold (COGS) incl. D&A
84.90
119.00
187.00
3,901.50
1,783.60
Gross Income
84.90
119.00
187.00
1,003.10
818.70
SG&A Expense
4,794.10
11,801.70
15,710.10
18,171.80
21,253.50
EBIT
4,879.00
11,920.70
15,897.10
17,168.70
20,434.80
Unusual Expense
1,695.90
90.00
-
799.30
421.90
Non Operating Income/Expense
167.50
-
10.30
185.90
214.20
Interest Expense
2,078.40
6,106.60
829.90
1,347.80
1,028.80
Pretax Income
8,477.30
17,799.60
16,579.70
19,002.20
20,772.20
Income Tax
272.80
1,423.90
252.90
179.90
9.20
Consolidated Net Income
8,204.40
16,375.70
16,326.80
18,822.30
20,763
Net Income
8,204.40
16,375.70
16,326.80
18,822.30
20,763
Net Income After Extraordinaries
8,204.40
16,375.70
16,326.80
18,822.30
20,763
Net Income Available to Common
8,204.40
16,375.70
16,326.80
18,822.30
20,763
EPS (Basic)
51.68
0.69
0.39
0.31
0.21
Basic Shares Outstanding
158.90
23,683.80
41,510.10
61,404.10
100,395.60
EPS (Diluted)
51.63
0.69
0.39
0.31
0.21
Diluted Shares Outstanding
158.90
23,683.80
41,510.10
61,404.10
100,395.60
EBITDA
4,794.10
11,801.70
15,710.10
16,292.30
18,755.30
Non-Operating Interest Income
8.50
137.70
157.60
127.70
483.80
About Profound Medical
View Profile
